Literature DB >> 7576659

Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins.

J Aiyar1, J M Withka, J P Rizzi, D H Singleton, G C Andrews, W Lin, J Boyd, D C Hanson, M Simon, B Dethlefs.   

Abstract

The architecture of the pore-region of a voltage-gated K+ channel, Kv1.3, was probed using four high affinity scorpion toxins as molecular calipers. We established the structural relatedness of these toxins by solving the structures of kaliotoxin and margatoxin and comparing them with the published structure of charybdotoxin; a homology model of noxiustoxin was then developed. Complementary mutagenesis of Kv1.3 and these toxins, combined with electrostatic compliance and thermodynamic mutant cycle analyses, allowed us to identify multiple toxin-channel interactions. Our analyses reveal the existence of a shallow vestibule at the external entrance to the pore. This vestibule is approximately 28-32 A wide at its outer margin, approximately 28-34 A wide at its base, and approximately 4-8 A deep. The pore is 9-14 A wide at its external entrance and tapers to a width of 4-5 A at a depth of approximately 5-7 A from the vestibule. This structural information should directly aid in developing topological models of the pores of related ion channels and facilitate therapeutic drug design.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576659     DOI: 10.1016/0896-6273(95)90104-3

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  55 in total

1.  UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.

Authors:  D C Hanson; A Nguyen; R J Mather; H Rauer; K Koch; L E Burgess; J P Rizzi; C B Donovan; M J Bruns; P C Canniff; A C Cunningham; K A Verdries; E Mena; J C Kath; G A Gutman; M D Cahalan; S Grissmer; K G Chandy
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Regulation of transient Na+ conductance by intra- and extracellular K+ in the human delayed rectifier K+ channel Kv1.5.

Authors:  Z Wang; X Zhang; D Fedida
Journal:  J Physiol       Date:  2000-03-15       Impact factor: 5.182

Review 3.  Molecular properties and physiological roles of ion channels in the immune system.

Authors:  M D Cahalan; H Wulff; K G Chandy
Journal:  J Clin Immunol       Date:  2001-07       Impact factor: 8.317

4.  Block of the lymphocyte K(+) channel mKv1.3 by the phenylalkylamine verapamil: kinetic aspects of block and disruption of accumulation of block by a single point mutation.

Authors:  R J Röbe; S Grissmer
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

5.  Permeation and block of the Kv1.2 channel examined using brownian and molecular dynamics.

Authors:  Dan Gordon; Shin-Ho Chung
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

6.  Modeling the binding of three toxins to the voltage-gated potassium channel (Kv1.3).

Authors:  Rong Chen; Anna Robinson; Dan Gordon; Shin-Ho Chung
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

7.  Scorpion toxins prefer salt solutions.

Authors:  Azadeh Nikouee; Morteza Khabiri; Lukasz Cwiklik
Journal:  J Mol Model       Date:  2015-10-16       Impact factor: 1.810

Review 8.  Peptide toxins and small-molecule blockers of BK channels.

Authors:  Mu Yu; San-ling Liu; Pei-bei Sun; Hao Pan; Chang-lin Tian; Long-hua Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

9.  Structural and functional consequences of the presence of a fourth disulfide bridge in the scorpion short toxins: solution structure of the potassium channel inhibitor HsTX1.

Authors:  P Savarin; R Romi-Lebrun; S Zinn-Justin; B Lebrun; T Nakajima; B Gilquin; A Menez
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

Review 10.  Molecular diversity and regulation of renal potassium channels.

Authors:  Steven C Hebert; Gary Desir; Gerhard Giebisch; Wenhui Wang
Journal:  Physiol Rev       Date:  2005-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.